Historical perspective on movement disorders

Journal of Clinical Psychiatry

Volumn 65, Issue SUPPL. 9, 2004, Pages 3-8

  Friedman, Joseph H ^a,b  

^a BROWN UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ARTICLE; DYSKINESIA; HISTORY; HUMAN; INCIDENCE; MOTOR DYSFUNCTION; PREVALENCE; SCHIZOPHRENIA;

ANTIPSYCHOTIC AGENTS; DYSKINESIA, DRUG-INDUCED; HISTORY, 20TH CENTURY; HUMANS; INCIDENCE; MOVEMENT DISORDERS; PREVALENCE; SCHIZOPHRENIA;

EID: 3042701262     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Psychopharmacology Research Branch NIMH. Abnormal Involuntary Movement Scale (AIMS). In: Guy W. ECDEU Assessment Manual for Psychopharmacology, Revised. US Dept Health, Education, and Welfare Publication (ADM) 76-338. Rockville, Md: National Institute of Mental Health; 1976:534-537
2. Bleuler E. Dementia Praecox or the Group of Schizophrenias. Zinkin J, trans. New York, NY: International Universities Press; 1950
3. Kraepelin EP. Dementia Praecox and Paraphrenia. Barclay RM, trans. Robertson GM, ed. Huntington, NY: Robert E. Krieger Publishing Co Inc; 1971
4. Fenton WS. Prevalence of spontaneous dyskinesia in schizophrenia. J Clin Psychiatry 2000;61(suppl 4):10-14
5. Casey DE. Tardive dyskinesia: pathophysiology and animal models. J Clin Psychiatry 2000;61(suppl 4):5-9
6. Chatterjee A, Chakos M, Koreen A, et al. Prevalence and clinical correlates of extrapyramidal signs and spontaneous dyskinesia in never-medicated schizophrenic patients. Am J Psychiatry 1995;152:1724-1729
7. Fenton WS, Blyler CR, Wyatt RJ, et al. Prevalence of spontaneous dyskinesia in schizophrenic and in schizophrenic and non-schizophrenic psychiatric patients. Br T Psychiatry 1997;171:265-268
8. McCreadie RG, Padmavati R, Thara R, et al. Spontaneous dyskinesia and parkinsonism in never-medicated, chronically ill patients with schizophrenia: 18-month follow-up. Br J Psychiatry 2002;181:135-137
9. Schooler NR, Kane JM. Research diagnoses for tardive dyskinesia [letter]. Arch Gen Psychiatry 1982;39:486-487
10. McCreadie RG, Thara R, Srinivasan TN, et al. Spontaneous dyskinesia in first-degree relatives of chronically ill, never-treated people with schizophrenia. Br J Psychiatry 2003;183:45-49
11. Mettler FA, Crandell A. Neurologic disorders in psychiatric institutions. J Nerv Ment Dis 1959;128:148-159
12. Merritt HH, Adams RD, Solomon HC. Neurosyphilis. New York, NY: Oxford University Press; 1946
13. Friedman JH. Stereotypy and catatonia. In: Jankovic J, Tolosa E, eds. Parkinson's Disease and Movement Disorders. 3rd ed. Baltimore, Md: Williams and Wilkins; 1988:709-728
14. Bourgeois M, Bouilh P, Tignol J, et al. Spontaneous dyskinesias vs neuroleptic-induced dyskinesias in 270 elderly subjects. J Nerv Ment Dis 1980;168:177-178
15. Blowers AJ, Borison RL, Blowers CM, et al. Abnormal involuntary movements in the elderly. Br J Psychiatry 1981;139:363-364
16. Klawans HL, Barr A. Prevalence of spontaneous lingual-facial-buccal dyskinesias in the elderly. Neurology 1982;32:558-559
17. Kane JM, Weinhold P, Kinon B, et al. Prevalence of abnormal involuntary movements ("spontaneous dyskinesias") in the normal elderly. Psychopharmacology (Berl) 1982;77:105-108
18. Kopala LC. Spontaneous and drug-induced movement disorders in schizophrenia. Acta Psychiatr Scand Suppl 1996;389:12-17
19. Schönecker M. Ein eigentumliches syndrom im oralen Beriech bei Megaphenapplikation. [Paroxysmal dyskinesia as the effect of megaphen.]. Nervenarzt 1957;28:550-553
20. Tarsy D. History and definition of tardive dyskinesia. Clin Neuropharmacol 1983;6:91-99
21. Delay J, Deniker P. Drug-induced extra-pyramidal syndromes. In: Vinken PJ, Bruyn GW, eds. Diseases of the Basal Ganglia. New York, NY: Elsevier North Holland; 1968:248-266
22. Sigwald J, Bouttier D, Raymondeaud C, et al. Quatre cas de dyskinésie facio-bucco-linguo-masticatrice à ĺvolution prolongée secondaire à un traitment par les neuroleptiques. Rev Neurol (Paris) 1959;100:751-755
23. Tanner CM. Drug induced movement disorders (tardive dyskinesia and dopa-induced dyskinesia). In: Vinken PJ, Bruyn GW, eds. Extrapyramidal Movement Disorders. New York, NY: Elsevier North Holland; 1986
24. Kruse W. Persistent muscular restlessness after phenothiazine treatment: report of 3 cases [letter]. Am J Psychiatry 1960;117:152-153
25. Druckman R, Seelinger D, Thulin B. Chronic involuntary movements induced by phenothiazines. J Nerv Ment Dis 1962;135:69-76
26. Fernandez HH, Friedman JH. Classification and treatment of tardive syndromes. Neurolog 2003;9:16-27
27. Hunter R, Earl CJ, Janz D. A syndrome of abnormal movements and dementia in leucotomized patients treated with phenothiazines. J Neurol Neurosurg Psychiatry 1964;27:219-223
28. Hunter R, Earl CJ, Thornicroft S. An apparently irreversible syndrome of abnormal movements following phenothiazine medication. Proc R Soc Med 1964;57:758-762
29. Faurbye A, Rasch PJ, Petersen PB, et al. Neurological symptoms in pharmacotherapy of psychoses. Acta Psychiatr Scand 1964;40:10-27
30. A side effect of phenothiazines [The London Letter]. CMAJ 1964;91:1081
31. Ayd FJ. A survey of drug-induced extrapyramidal reactions. JAMA 1961;175:1054-1060
32. Degkwitz R, Wenzel W. Persistent extrapyramidal side effects after long-term application of neuroleptics. In: Brill H, Cole J, Deniker P, et al, eds. Neuropsychopharmacology: Proceedings of the 5th Collegium Internationale Neuropsychopharmacologicum. Amsterdam, the Netherlands: Excerpta Medica; 1967:608-615
33. Crane GE. Persistent dyskinesia. Br J Psychiatry 1973;122:395-405
34. Kline NS. On the rarity of "irreversible" oral dyskinesias following phenothiazines. Am J Psychiatry 1968;124(suppl 40):48-54
35. Turek IS. Drug induced dyskinesia: reality or myth? Dis Nerv Syst 1975;36:397-399
36. Curran JP. Tardive dyskinesia: side effect or not? Am J Psychiatry 1973;130:406-410
37. Baldessarini RJ, Cole JO, Davis JM, et al. Tardive Dyskinesia: Report of the American Psychiatric Association Task Force on Late Neurological Effects of Antipsychotic Drugs. Task Force Report 18 ed. Washington, DC: The American Psychiatric Association; 1979
38. Uhrbrand L, Faurbye A. Reversible and irreversible dyskinesia after treatment with perphenazine, chlorpromazine, reserpine, and electroconvulsive therapy. Psychopharmacologia 1960;1:408-418
39. Degkwitz R, Binsack KF, Herkert H, et al. Das terminale extrapyramidale Insuffizienz-bzw. Defecktsyndrom infolge chronischer Anwendung von Neuroleptics. [On the problem of persistent extrapyramidal hyperkinesia following prolonged use of neuroleptics.]. Nervenarzt 1967;38:170-174
40. Crane GE. Tardive dyskinesia in patients treated with major neuroleptics: a review of the literature. Am J Psychiatry 1968;124(suppl 40):40-48
41. Crane GE. Clinical psychopharmacology in its 20th year: late, unanticipated effects of neuroleptics may limit their use in psychiatry. Science 1973;181:124-128
42. Crane GE, Gardner R Jr, eds. Psychotropic Drugs and Dysfunctions of the Basal Ganglia. Washington, DC: US Public Health Service; 1969. Publication 1938
43. Davis JM, Chen N, Glick ID. A meta-analysis of the efficacy of second-generation antipsychotics. Arch Gen Psychiatry 2003;60:553-564
44. Kane JM. Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence. J Clin Psychiatry 2004;65(suppl 9):16-20